Cargando…

Evaluation of Single Dose and Fractionated Dose of I-131 Radiolabeled Nanoparticles for Triple-Negative Breast Cancer Treatment

Combination chemotherapy is still the standard clinical care for triple-negative breast cancer (TNBC). However, sodium iodide symporter (NIS) uptake by TNBC has opened the potential of NIS as a molecular target for radioiodine theranostic treatments. Radiolabeled poly(lactic-co-glycolic) acid nanoca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marshall, Suphalak Khamruang, Kaewpradit, Nutnicha, Mudmarn, Tavadee, Buathong, Jirassaya, Sriwirote, Palmuk
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452573/ https://www.ncbi.nlm.nih.gov/pubmed/37626666 http://dx.doi.org/10.3390/biomedicines11082169

Ejemplares similares

Anti-EpCAM Functionalized I-131 Radiolabeled Biomimetic Nanocarrier Sodium/Iodide-Symporter-Mediated Breast-Cancer Treatment
por: Marshall, Suphalak Khamruang, et al.
Publicado: (2022)

Anti-EGFR Targeted Multifunctional I-131 Radio-Nanotherapeutic for Treating Osteosarcoma: In Vitro 3D Tumor Spheroid Model
por: Marshall, Suphalak Khamruang, et al.
Publicado: (2022)

Assessment of Radiation Exposure in a Nuclear Medicine Department during (99m)Tc-MDP Bone Scintigraphy
por: Marshall, Suphalak Khamruang, et al.
Publicado: (2023)

Biomimetic Targeted Theranostic Nanoparticles for Breast Cancer Treatment
por: Marshall, Suphalak Khamruang, et al.
Publicado: (2022)

Dose fractionation effects with negative pions
por: Bianchi, M, et al.
Publicado: (1980)

Intrathecal administration of 131I radiolabelled monoclonal antibody as a treatment for neoplastic meningitis.
por: Moseley, R. P., et al.
Publicado: (1990)

Comparison of absorbed dose extrapolation methods for mouse-to-human translation of radiolabelled macromolecules
por: Cicone, Francesco, et al.
Publicado: (2022)

Secondary cancer risk from modern external-beam radiotherapy of prostate cancer patients: Impact of fractionation and dose distribution
por: Sitathanee, Chomporn, et al.
Publicado: (2021)

Impact of sweating on equivalent dose of patients treated with (131)Iiodine
por: Haghighatafshar, Mahdi, et al.
Publicado: (2016)

Radiolabeled Nanoparticles for Multimodality Tumor Imaging
por: Xing, Yan, et al.
Publicado: (2014)

Radiolabeling of Nanoparticles and Polymers for PET Imaging
por: Stockhofe, Katharina, et al.
Publicado: (2014)

Radiolabeled theranostics: magnetic and gold nanoparticles
por: Same, Saeideh, et al.
Publicado: (2016)

Radio-enhancement effects by radiolabeled nanoparticles
por: Gholami, Yaser Hadi, et al.
Publicado: (2019)

Recent Insights in Barium-131 as a Diagnostic Match for Radium-223: Cyclotron Production, Separation, Radiolabeling, and Imaging †
por: Reissig, Falco, et al.
Publicado: (2020)

SUN-131 The Roles of Two Insulin Receptor Isoforms in Triple Negative Breast Cancer Growth
por: Kang, Chifei, et al.
Publicado: (2020)

Radiolabeled PET/MRI Nanoparticles for Tumor Imaging
por: Forte, Ernesto, et al.
Publicado: (2019)

Radiolabeled Gold Nanoparticles for Imaging and Therapy of Cancer
por: Silva, Francisco, et al.
Publicado: (2020)

Thyroid Remnant Estimation by Diagnostic Dose (131) I Scintigraphy or (99m) T c O (4) (−) Scintigraphy after Thyroidectomy: A Comparison with Therapeutic Dose (131) I Imaging
por: Liu, Guanghui, et al.
Publicado: (2016)

The Effect of Diagnostic Absorbed Doses from (131)I on Human Thyrocytes in Vitro
por: Adamczewski, Zbigniew, et al.
Publicado: (2015)

Received dose variability after administration of I‐131 for treatment of hyperthyroidism in cats
por: Busser, Suzanne, et al.
Publicado: (2021)

Thyroid dose assessments due to inhalation of (131)I for nuclear medicine workers
por: Liu, Gang, et al.
Publicado: (2022)

Low Doses of Silver Nanoparticles Selectively Induce Lipid Peroxidation and Proteotoxic Stress in Mesenchymal Subtypes of Triple-Negative Breast Cancer
por: Snyder, Christina M., et al.
Publicado: (2021)

Comparative Study of Two Oxidizing Agents, Chloramine T and Iodo-Gen(®), for the Radiolabeling of β-CIT with Iodine-131: Relevance for Parkinson’s Disease
por: R. Durante, Ana Claudia, et al.
Publicado: (2019)

Dose-response effect of Gelofusine on renal uptake and retention of radiolabelled octreotate in rats with CA20948 tumours
por: Melis, Marleen, et al.
Publicado: (2009)

Whole organ and islet of Langerhans dosimetry for calculation of absorbed doses resulting from imaging with radiolabeled exendin
por: van der Kroon, Inge, et al.
Publicado: (2017)

Emerging role of radiolabeled nanoparticles as an effective diagnostic technique
por: de Barros, AndréLuís Branco, et al.
Publicado: (2012)

(7)Be-recoil radiolabelling of industrially manufactured silica nanoparticles
por: Holzwarth, Uwe, et al.
Publicado: (2014)

Methods for Radiolabelling Nanoparticles: SPECT Use (Part 1)
por: Varani, Michela, et al.
Publicado: (2022)

Methods for Radiolabelling Nanoparticles: PET Use (Part 2)
por: Bentivoglio, Valeria, et al.
Publicado: (2022)

Methods for Radiolabeling Nanoparticles (Part 3): Therapeutic Use
por: Bentivoglio, Valeria, et al.
Publicado: (2023)

Low-Dose and Long-Term Olaparib Treatment Sensitizes MDA-MB-231 and SUM1315 Triple-Negative Breast Cancers Spheroids to Fractioned Radiotherapy
por: Dubois, Clémence, et al.
Publicado: (2019)

Atezolizumab in metastatic triple-negative breast cancer: IMpassion130 and 131 trials - how to explain different results?
por: Franzoi, Maria Alice, et al.
Publicado: (2020)

I-131 Dose Response for Incident Thyroid Cancers in Ukraine Related to the Chornobyl Accident
por: Brenner, Alina V., et al.
Publicado: (2011)

(131)I age-dependent inhalation dose in Southern Poland from Fukushima accident
por: Brudecki, K., et al.
Publicado: (2016)

MON-559 Inappropriate Dosing of I-131 in Non-Metastatic Differentiated Thyroid Cancer
por: Alzenaidi, Ahlam, et al.
Publicado: (2019)

Iodine-125 radiolabeling of silver nanoparticles for in vivo SPECT imaging
por: Chrastina, Adrian, et al.
Publicado: (2010)

Therapeutic dosing and targeting efficacy of Pt-Mal-LHRH towards triple negative breast cancer
por: Ndinguri, Margaret, et al.
Publicado: (2023)

Empiric Therapy with Low-Dose I-131 in Differentiated Cancer Thyroid: What is the Magic Number?
por: Shinto, Ajit S., et al.
Publicado: (2013)

Outcome of (131)I therapy in hyperthyroidism using a 550MBq fixed dose regimen
por: Lewis, Anthony, et al.
Publicado: (2013)

Optimizing reconstruction parameters for quantitative (124)I-PET in the presence of therapeutic doses of (131)I
por: Fanchon, Louise M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3gmiqd8nuojjav7qlvi3l2bgo1